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, Abstract—Background: Benign paroxysmal positional
vertigo (BPPV) is a common presenting problem. Objective:
Our aim was to compare the efficacy of vestibular rehabilitation (maneuver) vs. conventional therapy (medications) in
patients presenting to the emergency department (ED) with
BPPV. Methods: This was a prospective, single-blinded
physician, randomized pilot study comparing two groups
of patients who presented to the ED with a diagnosis of
BPPV at a Level 1 trauma center with an annual census of
approximately 75,000. The first group received standard
medications and the second group received a canalith repositioning maneuver. The Dizziness Handicap Inventory was
used to measure symptom resolution. Results: Twenty-six patients were randomized; 11 to the standard treatment arm
and 15 to the interventional arm. Mean age ± standard deviation of subjects randomized to receive maneuver and medication were 59 ± 12.6 years and 64 ± 11.2 years, respectively.
There was no significant difference in mean ages between the
two treatment arms (p = 0.310). Two hours after treatment,
the symptoms between the groups showed no difference in
measures of nausea (p = 0.548) or dizziness (p = 0.659).
Both groups reported a high level of satisfaction, measured
on a 0 10 scale. Satisfaction in subjects randomized to
receive maneuver and medication was 9 ± 1.5 and 9 ± 1.0,
respectively; there was no significant difference in satisfaction between the two arms (p = 0.889). Length of stay during
the ED visit did not differ between the treatment groups
(p = 0.873). None of the patients returned to an ED for similar
symptoms. Conclusions: This pilot study shows promise, and
would suggest that there is no difference in symptomatic

resolution, ED length of stay, or patient satisfaction between
standard medical care and canalith repositioning maneuver.
Physicians should consider the canalith repositioning maneuver as a treatment option. Ó 2014 Elsevier Inc.
, Keywords—vestibular rehabilitation; benign paroxysmal positional vertigo; ED

INTRODUCTION
Vertigo is a common complaint of patients who seek care
in the emergency department (ED) (1). Vertigo is a
frequent symptom in the general population, with a
12-month prevalence of 5% and an incidence of 1.4% in
adults; its prevalence rises with age and is about two to
three times higher in women than in men (2). Benign
paroxysmal positional vertigo (BPPV) is characterized
by brief periods of vertigo triggered by a change in the position of a person’s head relative to gravity (3). It is the
most common disorder, accounting for one third of vestibular diagnoses in the general population (4). It was first
described by Barany in 1921 and was later described in
more detail by Dix and Hallpike in 1952 (5,6).
It is common practice for ED physicians to treat these
patients symptomatically with benzodiazepines, antihistamines, or anticholinergic medications (7). The canalith repositioning maneuver was developed by Epley (8). This
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repositioning maneuver is considered an effective treatment for BPPV (9). However, many existing studies
have used a sham/placebo in the comparator arm (10 14).
We set out to compare the efficacy of vestibular rehabilitation vs. conventional therapy in ED patients who
present with BPPV. In particular, we sought to evaluate
the improvement of vertigo in patients diagnosed with
BPPV in the ED, assess their disposition time, and
compare patient satisfaction between those patients who
receive standard care vs. those who received vestibular
rehabilitation.
METHODS
This was a prospective, single-blinded physician, randomized pilot study comparing two groups of patients
who presented to the ED with a diagnosis of BPPV at a
Level 1 trauma center with an annual census of approximately 75,000. After Institutional Review Board approval
and clinical trial registration, we enrolled subjects during
weekday hours from February 2006 through December
2009. The first group received standard treatment of medications to alleviate their symptoms, and the second group
received vestibular rehabilitation treatment with the canalith repositioning maneuver.
The algorithm for treatment can be viewed in Figure 1.
BPPV was diagnosed based on findings obtained from the
Dix-Hallpike maneuver (DH) by a blinded physician
assessor. We considered the DH test positive, consistent
with the literature, when the maneuver elicited reproducible vertigo and exhibited a brief latency period, with fatigability and reversal of the nystagmus on return to upright
(15). For purposes of this trial, the nystagmus resolved or
fatigued in < 60 s. If the DH test was positive, inclusion
and exclusion criteria were applied and the patient was
approached for consent and enrollment.
To be included in the study, patients had to be at least
18 years of age, presenting to the ED weekdays during
business hours, and have a positive DH test. Patients
were excluded if they had taken any antihistamines or anticholinergics within the past 12 h, if they were unable to
ambulate, had severe cervical spine disease or known cerebral vascular disease, or had any positive findings during the neurological examination during physical
examination that caused concern that the primary diagnosis was not BPPV. Patients were also excluded if they
had known Meniere’s disease; any cardiac complaints;
loss of consciousness; previous enrollment; mental conditions that rendered them unable to understand the nature,
scope, and consequences of the study; or were unlikely to
comply with the study, such as those with uncooperative
attitudes or any other condition that could confound or
interfere with evaluation or prevent compliance with the
study protocol. Patients who had a negative finding of

vertigo and nystagmus when the DH maneuver was performed by the physical therapist or a trained research staff
nurse were also excluded, even if the patient had a positive
finding of vertigo and nystagmus when the DH maneuver
was performed by the physician or resident.
Inter-rater reliability analysis was completed by the
physical therapists and nurse researchers before the study
using video analysis of nystagmus and post test of technique by a physical therapist certified in vestibular rehabilitation.
After consent and the DH confirmed to be positive with
involvement of unilateral or bilateral ears by the therapist/
research staff nurse, the patients were randomized into
one of the treatment arms using a computer-generated
sequence. The control group received medications to alleviate their symptoms as per provider preference,
including treatments such as benzodiazepines, antihistamines, antiemetics, and IV fluids. The experimental group
received treatment with the canalith repositioning maneuver. The canalith repositioning maneuver was repeated up
to two times, if necessary, during the ED visit to attempt
full resolution of symptoms.
In both groups, the research staff assessed for symptom resolution every 15 min for the first hour, then every
30 min up to 2 h or until symptom resolution or physician
reassessment is complete using a visual analogue scale,
one measuring dizziness and another to measure nausea.
There was then a repeat assessment of the DH on patients
in both groups. Those patients who were in the experimental group who continued to have symptoms at 2 h
after treatment with the canalith repositioning maneuver
were considered treatment failures and were treated with
medications as deemed appropriate by the ED physician.
Patients were discharged with either standard instruction
for follow-up or, in the case of the intervention group,
with instructions to follow-up with physical therapy or
a vestibular clinic.
Phone follow-up assessing any repeat ED visits and
satisfaction with their treatment, and the Dizziness Handicap Inventory short form (Figure 2) measure was performed (a previously validated tool for measurement of
nausea and dizziness on a severity scale) (16).
The study protocol allowed for statistical consultation
and data peak power interim analysis conduction to
calculate the exact sample size needed to complete the
study. The study was terminated at this analysis because
the hypothesis had already been tested and changes in
prehospital protocols that allowed medications to be
given precluded reasonable continued enrollment.
Statistical Methods
Incidence rates and categorical variables were summarized and reported using counts, percentages, and exact
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Figure 1. Algorithm for treatment of benign paroxysmal positional vertigo. TIA = transient ischemic attack; CT = computed
tomography; MRI = magnetic resonance imaging; ENT = ear, nose, and throat.

95% binomial confidence intervals. Differences between
the proportions by randomized treatment assignment
were compared using a two-tailed Fisher’s exact test.
Continuous variables were summarized using means,
standard deviations, and 95% confidence intervals and
compared using a one-factor (randomized treatment
assignment) analysis of variance test. Multinomial parameters, such as patient satisfaction (0 10 score) and
the Dizziness Handicap Inventory (0 13 score) were
compared using a Wilcoxon two-sample test. Probability
values < 0.05 were considered significant; p values > 0.1
but $ 0.5 were considered highly suggestive of a significant difference. All analyses were conducted using SAS
software, version 9.2 (SAS Institute, Cary, NC).
RESULTS
Twenty-six patients were randomized and enrolled;
11 into the standard treatment arm and 15 into the interventional arm. Two subjects in the interventional arm
were considered treatment failures. One did not complete

due to nausea, and the second received the manipulation
and then needed medication. See the CONSORT
(Consolidated Standards of Reporting Trials) diagram
in Figure 3. Ages (mean 6 standard deviation [SD]) of
subjects randomized to receive maneuver and medication
was 59 6 12.6 years and 64 6 11.2 years, respectively;
there was no significant difference in the patient age
between the two treatment arms (p = 0.310). Although
not significant (p = 0.111), there was a considerable difference in sex between the two treatment groups; 67%
females in the maneuver group vs. 27% in the medication
group. Two hours after the initiation of treatment, the
symptoms between the two groups showed no difference
in the primary outcome measures of nausea (p = 0.548;
maneuver mean = 4.0 and median = 1.0; medication
mean = 8.0 and median = 3.0) or dizziness (p = 0.659;
maneuver mean = 9.0 and median = 6.0; medication
mean = 14.0 and median = 5.0).
Both groups of patients reported a high level of satisfaction as measured on a 0 10 scale. Satisfaction in patients randomized to receive maneuver and medication

Downloaded for library services (libraryservices@lvhn.org) at Lehigh Valley Health Network from ClinicalKey.com by Elsevier on
August 24, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

578

R. R. Sacco et al.

Figure 2. Dizziness Handicap Inventory short form.

was 9 6 1.5 and 9 6 1.0, respectively; there was no significant difference in satisfaction of patients between the
two treatment arms (p = 0.889) (Figure 4).
The length of stay (LOS) during the ED visit did
not differ between the randomized treatment groups
(p = 0.873). The LOS was 338 6 141 min for patients
randomized to receive maneuver and 346 6 95.9 min
for patients randomized to receive medication (Figure 5).
Seventy-three percent of participants were available
for phone follow-up at 1 week and all patients were contacted 30 days post procedure. Responses at the 30-day
follow-up revealed that there was no difference between
the group in the Dizziness Handicap Inventory measure
(p = 0.236) and no difference in patient satisfaction between the two groups (p = 0.721). For the short-form
Dizziness Handicap Inventory, based on a 0 (maximum
dizziness) to 13 (no dizziness) score, the mean 6 SD
scores were 11.9 6 2.00 for patients randomized to

receive maneuver and 10.7 6 2.57 for patients randomized to receive medication. None of the patients had
returned to an ED for similar symptoms. Six of the 15
(40%) patients in the maneuver group and 3 of the 11
(27%) patients in the medication group did seek other
treatment for similar symptoms within 30 days of the primary ED visit; the difference in the proportions was not
significant (p = 0.683). This same distribution and proportion of patients reported they receive physical therapy or
had gone to a vestibular clinic for their condition.
DISCUSSION
The preponderance of the literature, as well as the current
study, suggest that the canalith repositioning maneuver
should be entertained as standard of care in the ED for
treatment of BPPV. Yet, a recent study suggests that use
of the DH test in ED patients with dizziness is decreasing
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Figure 3. CONSORT (Consolidated Standards of Reporting Trials) diagram.

over time and the canalith repositioning maneuver is used
in only 3.9% of those with BPPV (17). What barriers exist
that prevent its regular use is difficult to explain. However, it is hoped that this article will help alleviate concerns
about LOS, symptom resolution, or patient satisfaction.
Considering the cost savings, nursing time, and potential
for adverse reactions to medications (even the limits on
driving due to sedation) and complications from IV access, it seems that the maneuver has clear advantages
for those so motivated to attempt it. This study was facilitated by a therapist and research nurse trained in vestibular rehabilitation. We did not assess, nor do we know of
any studies that have assessed, physician to therapist performance of otolith repositioning techniques. The maneuver itself is not complex; further study could determine

Figure 4. Patient satisfaction with the treatment administered.

what resources could be best utilized in the delivery of
the treatment (i.e., nursing staff, resident, or attending
physician).
Limitations
Generalizability is brought into question because this was
performed at a single site in Pennsylvania. Seven subjects
were not available for phone follow-up at 1 week; the
strength of the outcomes we report must be weighed
against the 27% that cannot be reported.
Although there were no differences observed relative
to patient characteristics, additional investigation is
warranted to define the response rate in specific patient
subsets where maneuver or medication might be contraindicated. In particular, we have not looked at the

Figure 5. Length of stay (min) in the emergency department.
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incidence of BPPV compared with acute vestibular syndrome in our ED, nor can we comment on the incidence
in our ED as it compares with other EDs. Additionally,
some of our BPPV patients might have had horizontal
canal BPPV; while Epley has been demonstrated to be
useful in these patients, the frequency and outcome of
its use might not be as well documented (18). Patients
were only enrolled during weekday hours and this was
a causal factor in the lengthy study period. This may
have allowed for sampling bias in the population studied.
CONCLUSIONS
Although small in sample size, this pilot study shows
promise, and would suggest that there is no difference
in symptomatic resolution, ED LOS, or patient satisfaction between standard medical care and canalith repositioning maneuver. Physicians should consider the
canalith repositioning maneuver as a treatment option.
Acknowledgments—Statistical analysis was performed by Bruce
C. Stouch, PhD, biostatistician.
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ARTICLE SUMMARY
1. Why is this topic important?
Benign paroxysmal positional vertigo is a common presenting problem to the emergency department (ED).
2. What does this study attempt to show?
We set out to compare the efficacy of vestibular rehabilitation vs. conventional therapy in ED patients who present with BPPV.
3. What are the key findings?
There is no difference in symptomatic resolution and
patient satisfaction between standard medical care and canalith repositioning maneuver in this study.
4. How is patient care impacted?
Physicians should consider canalith repositioning maneuver as part of their standard of care.

Downloaded for library services (libraryservices@lvhn.org) at Lehigh Valley Health Network from ClinicalKey.com by Elsevier on
August 24, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

